The retinoblastoma protein (Rb) is one of the most important tumor suppressors, as illustrated by the fact that either Rb itself or some of its pathway components is the target of oncogenic driver mutations in most, if not all, human cancers [1–8]. Here, RB1 is linked to neoplasm.